TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Avelumab Market Research Report 2024(Status and Outlook)

Global Avelumab Market Research Report 2024(Status and Outlook)

  • Category:Life Sciences
  • Published on : 02 October 2024
  • Pages :96
  • Formats:
  • Report Code:SMR-8010048
OfferClick for best price

Best Price: $2600

Avelumab Market Size, Share 2024


Market size in 2024 US$ 1.23 billion
Forecast Market size by 2030 US$ 2.18 billion
Growth Rate CAGR of 10.0% Number of Pages 96 Pages

The global Avelumab market size was valued at US$ 1.23 billion in 2024 and is projected to reach US$ 2.18 billion by 2030, at a CAGR of 10.0% during the forecast period 2024-2030.

United States Avelumab market size was valued at US$ 562 million in 2024 and is projected to reach US$ 987 million by 2030, at a CAGR of 9.8% during the forecast period 2024-2030.

Avelumab is a human monoclonal antibody used in immunotherapy for various types of cancer, including Merkel cell carcinoma and urothelial carcinoma.

Strong growth driven by expanding approvals for multiple cancer types. Increasing adoption of immunotherapies in cancer treatment. Ongoing clinical trials exploring new indications potentially boosting market value.

Report Overview

This report provides a deep insight into the global Avelumab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Avelumab Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Avelumab market in any manner.

Global Avelumab Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

  • Merck
  • Pfizer

Market Segmentation (by Type)

  • By Usage
  • By Specifications

Market Segmentation (by Application)

  • Merkel-cell Carcinoma
  • Non-small Cell Lung Carcinoma (NSCLC)
  • Other

Geographic Segmentation

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Avelumab Market
  • Overview of the regional outlook of the Avelumab Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter

Report Attributes Report Details
Report Title Global Avelumab Market Research Report 2024(Status and Outlook)
Market size in 2024 US$ 1.23 billion
Forecast Market size by 2030 US$ 2.18 billion
Growth Rate CAGR of 10.0%
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2023
Forecast Year 2031
Number of Pages 96 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Avelumab
1.2 Key Market Segments
1.2.1 Avelumab Segment by Type
1.2.2 Avelumab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Avelumab Market Overview
2.1 Global Market Overview
2.1.1 Global Avelumab Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Avelumab Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Avelumab Market Competitive Landscape
3.1 Global Avelumab Sales by Manufacturers (2019-2024)
3.2 Global Avelumab Revenue Market Share by Manufacturers (2019-2024)
3.3 Avelumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Avelumab Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Avelumab Sales Sites, Area Served, Product Type
3.6 Avelumab Market Competitive Situation and Trends
3.6.1 Avelumab Market Concentration Rate
3.6.2 Global 5 and 10 Largest Avelumab Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Avelumab Industry Chain Analysis
4.1 Avelumab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Avelumab Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Avelumab Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Avelumab Sales Market Share by Type (2019-2024)
6.3 Global Avelumab Market Size Market Share by Type (2019-2024)
6.4 Global Avelumab Price by Type (2019-2024)
7 Avelumab Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Avelumab Market Sales by Application (2019-2024)
7.3 Global Avelumab Market Size (M USD) by Application (2019-2024)
7.4 Global Avelumab Sales Growth Rate by Application (2019-2024)
8 Avelumab Market Segmentation by Region
8.1 Global Avelumab Sales by Region
8.1.1 Global Avelumab Sales by Region
8.1.2 Global Avelumab Sales Market Share by Region
8.2 North America
8.2.1 North America Avelumab Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Avelumab Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Avelumab Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Avelumab Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Avelumab Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Avelumab Basic Information
9.1.2 Merck Avelumab Product Overview
9.1.3 Merck Avelumab Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Avelumab SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Pfizer
9.2.1 Pfizer Avelumab Basic Information
9.2.2 Pfizer Avelumab Product Overview
9.2.3 Pfizer Avelumab Product Market Performance
9.2.4 Pfizer Business Overview
9.2.5 Pfizer Avelumab SWOT Analysis
9.2.6 Pfizer Recent Developments
10 Avelumab Market Forecast by Region
10.1 Global Avelumab Market Size Forecast
10.2 Global Avelumab Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Avelumab Market Size Forecast by Country
10.2.3 Asia Pacific Avelumab Market Size Forecast by Region
10.2.4 South America Avelumab Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Avelumab by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Avelumab Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Avelumab by Type (2025-2030)
11.1.2 Global Avelumab Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Avelumab by Type (2025-2030)
11.2 Global Avelumab Market Forecast by Application (2025-2030)
11.2.1 Global Avelumab Sales (Kilotons) Forecast by Application
11.2.2 Global Avelumab Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Avelumab Market Size Comparison by Region (M USD)
Table 5. Global Avelumab Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Avelumab Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Avelumab Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Avelumab Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avelumab as of 2022)
Table 10. Global Market Avelumab Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Avelumab Sales Sites and Area Served
Table 12. Manufacturers Avelumab Product Type
Table 13. Global Avelumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Avelumab
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Avelumab Market Challenges
Table 22. Global Avelumab Sales by Type (Kilotons)
Table 23. Global Avelumab Market Size by Type (M USD)
Table 24. Global Avelumab Sales (Kilotons) by Type (2019-2024)
Table 25. Global Avelumab Sales Market Share by Type (2019-2024)
Table 26. Global Avelumab Market Size (M USD) by Type (2019-2024)
Table 27. Global Avelumab Market Size Share by Type (2019-2024)
Table 28. Global Avelumab Price (USD/Ton) by Type (2019-2024)
Table 29. Global Avelumab Sales (Kilotons) by Application
Table 30. Global Avelumab Market Size by Application
Table 31. Global Avelumab Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Avelumab Sales Market Share by Application (2019-2024)
Table 33. Global Avelumab Sales by Application (2019-2024) & (M USD)
Table 34. Global Avelumab Market Share by Application (2019-2024)
Table 35. Global Avelumab Sales Growth Rate by Application (2019-2024)
Table 36. Global Avelumab Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Avelumab Sales Market Share by Region (2019-2024)
Table 38. North America Avelumab Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Avelumab Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Avelumab Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Avelumab Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Avelumab Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Avelumab Basic Information
Table 44. Merck Avelumab Product Overview
Table 45. Merck Avelumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Avelumab SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Pfizer Avelumab Basic Information
Table 50. Pfizer Avelumab Product Overview
Table 51. Pfizer Avelumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Pfizer Business Overview
Table 53. Pfizer Avelumab SWOT Analysis
Table 54. Pfizer Recent Developments
Table 55. Global Avelumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Global Avelumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America Avelumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. North America Avelumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe Avelumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 60. Europe Avelumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific Avelumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Asia Pacific Avelumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America Avelumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. South America Avelumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa Avelumab Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa Avelumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global Avelumab Sales Forecast by Type (2025-2030) & (Kilotons)
Table 68. Global Avelumab Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global Avelumab Price Forecast by Type (2025-2030) & (USD/Ton)
Table 70. Global Avelumab Sales (Kilotons) Forecast by Application (2025-2030)
Table 71. Global Avelumab Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Avelumab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Avelumab Market Size (M USD), 2019-2030
Figure 5. Global Avelumab Market Size (M USD) (2019-2030)
Figure 6. Global Avelumab Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Avelumab Market Size by Country (M USD)
Figure 11. Avelumab Sales Share by Manufacturers in 2023
Figure 12. Global Avelumab Revenue Share by Manufacturers in 2023
Figure 13. Avelumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Avelumab Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Avelumab Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Avelumab Market Share by Type
Figure 18. Sales Market Share of Avelumab by Type (2019-2024)
Figure 19. Sales Market Share of Avelumab by Type in 2023
Figure 20. Market Size Share of Avelumab by Type (2019-2024)
Figure 21. Market Size Market Share of Avelumab by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Avelumab Market Share by Application
Figure 24. Global Avelumab Sales Market Share by Application (2019-2024)
Figure 25. Global Avelumab Sales Market Share by Application in 2023
Figure 26. Global Avelumab Market Share by Application (2019-2024)
Figure 27. Global Avelumab Market Share by Application in 2023
Figure 28. Global Avelumab Sales Growth Rate by Application (2019-2024)
Figure 29. Global Avelumab Sales Market Share by Region (2019-2024)
Figure 30. North America Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Avelumab Sales Market Share by Country in 2023
Figure 32. U.S. Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Avelumab Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Avelumab Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Avelumab Sales Market Share by Country in 2023
Figure 37. Germany Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Avelumab Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Avelumab Sales Market Share by Region in 2023
Figure 44. China Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Avelumab Sales and Growth Rate (Kilotons)
Figure 50. South America Avelumab Sales Market Share by Country in 2023
Figure 51. Brazil Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Avelumab Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Avelumab Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Avelumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Avelumab Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Avelumab Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Avelumab Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Avelumab Market Share Forecast by Type (2025-2030)
Figure 65. Global Avelumab Sales Forecast by Application (2025-2030)
Figure 66. Global Avelumab Market Share Forecast by Application (2025-2030)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount